You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • EP689 Cytoreduction and hyperthermic intraperitoneal chemotherapy followed by hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) in advanced peritoneal carcinomatous (APC) at the american university of beirut medical center (AUBMC) experience 2007–201…

Article info

Article menu
Download PDFPDF
ePoster
EP689 Cytoreduction and hyperthermic intraperitoneal chemotherapy followed by hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) in advanced peritoneal carcinomatous (APC) at the american university of beirut medical center (AUBMC) experience 2007–2018: a retrospective review

Authors

Citation

Abdallah R, Seoud M, El Housheimi A, et al
EP689 Cytoreduction and hyperthermic intraperitoneal chemotherapy followed by hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) in advanced peritoneal carcinomatous (APC) at the american university of beirut medical center (AUBMC) experience 2007–2018: a retrospective review
International Journal of Gynecologic Cancer 2019;29:A394.

Publication history

  • First published November 1, 2019.
Online issue publication 
March 03, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.